CY1119159T1 - Δισκιο το οποιο περιεχει 5-υδροξυ-1η-ιμιδαζολο-4-καρβοξαμιδiο - Google Patents

Δισκιο το οποιο περιεχει 5-υδροξυ-1η-ιμιδαζολο-4-καρβοξαμιδiο

Info

Publication number
CY1119159T1
CY1119159T1 CY20171100434T CY171100434T CY1119159T1 CY 1119159 T1 CY1119159 T1 CY 1119159T1 CY 20171100434 T CY20171100434 T CY 20171100434T CY 171100434 T CY171100434 T CY 171100434T CY 1119159 T1 CY1119159 T1 CY 1119159T1
Authority
CY
Cyprus
Prior art keywords
carboxamide
hydroxy
imidazolo
disc containing
tablet
Prior art date
Application number
CY20171100434T
Other languages
English (en)
Inventor
Yasuomi Yamasaki
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of CY1119159T1 publication Critical patent/CY1119159T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ένα δισκίο το οποίο περιέχει (1) 5-υδροξυ-1Η-ιμιδαζολο-4-καρβοξαμίδιο ή ένα άλας αυτού, ή έναν υδρίτη αυτού, και (2) διοξείδιο του πυριτίου, όπου η περιεκτικότητα του 5-υδροξυ-1Η-ιμιδαζολο-4-καρβοξαμιδίου, άλατος ή υδρίτη είναι υψηλή. Το δισκίο έχει ένα μέγεθος το οποίο καθιστά το δισκίο εύκολο στη λήψη και είναι εξαιρετικό όσον αφορά την ικανότητα αποδέσμευσης.
CY20171100434T 2013-01-15 2017-04-11 Δισκιο το οποιο περιεχει 5-υδροξυ-1η-ιμιδαζολο-4-καρβοξαμιδiο CY1119159T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013004995 2013-01-15
PCT/JP2014/050591 WO2014112530A1 (ja) 2013-01-15 2014-01-15 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミドを含有する錠剤

Publications (1)

Publication Number Publication Date
CY1119159T1 true CY1119159T1 (el) 2018-02-14

Family

ID=51209619

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100434T CY1119159T1 (el) 2013-01-15 2017-04-11 Δισκιο το οποιο περιεχει 5-υδροξυ-1η-ιμιδαζολο-4-καρβοξαμιδiο

Country Status (17)

Country Link
US (1) US9248102B2 (el)
EP (1) EP2946780B1 (el)
JP (1) JP5805891B2 (el)
CN (1) CN104271134B (el)
BR (1) BR112014027231A2 (el)
CY (1) CY1119159T1 (el)
DK (1) DK2946780T3 (el)
ES (1) ES2622568T3 (el)
HK (1) HK1205463A1 (el)
HR (1) HRP20170571T1 (el)
LT (1) LT2946780T (el)
PL (1) PL2946780T3 (el)
PT (1) PT2946780T (el)
RS (1) RS56032B1 (el)
RU (1) RU2654703C2 (el)
SI (1) SI2946780T1 (el)
WO (1) WO2014112530A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2018051971A1 (ja) * 2016-09-13 2018-03-22 富士フイルム株式会社 Ｍｌｌ関連白血病の予防または治療のための医薬、方法、使用及び化合物
EP3686189B1 (en) * 2017-10-27 2021-09-01 FUJIFILM Corporation Production method for 5-hydroxy-1h-imidazole-4-carboxamide-3/4hydrate
RU2018134165A (ru) * 2018-09-03 2020-04-01 Фуджифилм Корпорэйшн Комбинированное фармацевтическое, профилактическое или супрессивное средство для подавления резистентности к пиримидиновому антиметаболиту и способ лечения заболевания

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181731A (en) * 1976-09-07 1980-01-01 Sumitomo Chemical Company, Limited Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
JPS604802B2 (ja) 1976-09-07 1985-02-06 住友化学工業株式会社 制癌剤
JPS5824569A (ja) 1981-08-05 1983-02-14 Sumitomo Chem Co Ltd イミダゾ−ル誘導体の精製方法
JPS60185727A (ja) 1984-03-05 1985-09-21 Sumitomo Chem Co Ltd ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法
JPH048468A (ja) * 1990-04-27 1992-01-13 Sanshin:Kk ワーク研摩機
JPH09208468A (ja) * 1996-02-02 1997-08-12 Dainippon Pharmaceut Co Ltd ｐ−クロロ−Ｎ−（２−モルホリノエチル）ベンズアミドを含有する錠剤
WO2006046623A1 (ja) * 2004-10-25 2006-05-04 Japan Tobacco Inc. 溶解性及び安定性の改善された固形製剤及びその製造方法
JP5021210B2 (ja) * 2006-01-16 2012-09-05 エスエス製薬株式会社 圧縮成型製剤
FR2903695B1 (fr) * 2006-07-13 2008-10-24 Merck Sante Soc Par Actions Si Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
EP2407166B1 (en) * 2009-03-13 2013-08-21 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide

Also Published As

Publication number Publication date
WO2014112530A1 (ja) 2014-07-24
JPWO2014112530A1 (ja) 2017-01-19
PT2946780T (pt) 2017-04-26
CN104271134B (zh) 2016-06-29
RU2014143976A (ru) 2016-05-27
HK1205463A1 (zh) 2015-12-18
EP2946780A1 (en) 2015-11-25
SI2946780T1 (sl) 2017-05-31
US20150057324A1 (en) 2015-02-26
LT2946780T (lt) 2017-06-12
BR112014027231A2 (pt) 2017-06-27
EP2946780A4 (en) 2016-06-08
PL2946780T3 (pl) 2017-07-31
RS56032B1 (sr) 2017-09-29
EP2946780B1 (en) 2017-03-01
US9248102B2 (en) 2016-02-02
RU2654703C2 (ru) 2018-05-22
CN104271134A (zh) 2015-01-07
HRP20170571T1 (hr) 2017-08-11
DK2946780T3 (en) 2017-05-08
ES2622568T3 (es) 2017-07-06
JP5805891B2 (ja) 2015-11-10

Similar Documents

Publication Publication Date Title
CY1122695T1 (el) Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος
CL2015002562A1 (es) Anticuerpos e inmunoconjugados anti-b7-h4
TWD179502S (zh) 相機
DK3494985T3 (da) Vaccinesammensætning omfattende mutant calreticulin
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
DK3055380T3 (da) Kølemiddelblandinger omfattende difluormethan, pentafluorethan og tetrafluorpropen samt anvendelser deraf
CY1119159T1 (el) Δισκιο το οποιο περιεχει 5-υδροξυ-1η-ιμιδαζολο-4-καρβοξαμιδiο
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
EA201690036A1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
DK2958926T5 (da) Epidithiodioxopiperazinforbindelse eller derivater deraf og anvendelse deraf
MX2015011837A (es) Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada.
DK3046546T3 (da) Syntese og partikelmanipulation af co-krystaller
FI20135934A (fi) Hiiltä sisältävät komposiitit ja niiden sähkökemialliset applikaatiot
FR3007291B1 (fr) Composition cicatrisante et utlisation
TWD173712S (zh) 自動鉛筆
GB2548540B (en) Bis(2,2-bithienyl)methane derivate; molecularly imprinted polymer film; and associated methods of production and use thereof
CY1120402T1 (el) Νεο αλας ιμβαμπραδινης και μεθοδος παρασκευης αυτου
TWD178796S (zh) 收納箱
UA27039S (uk) Комплект знаків туристичних об'єктів
TH1501001574B (th) ข่าวสารสารสนเทศเสริมสมรรถนะเพิ่มเติมของคาบเวลาการบัฟเฟอร์ และของจุดการกู้คืน
CN302551294S (zh) U盘
TWD173995S (zh) 收納箱
TWD173996S (zh) 收納箱
TWD159172S (zh) 雪鏡